1 |
Gu GJ, Chung H, Park JY, Yoo R, Im HJ, Choi H, Lee YS, Seok SH. Mannosylated-serum albumin nanoparticle imaging to monitor tumor-associated macrophages under anti-PD1 treatment. J Nanobiotechnology 2023;21:31. [PMID: 36707872 DOI: 10.1186/s12951-023-01791-9] [Reference Citation Analysis]
|
2 |
Lei Y, Li X, Qin D, Zhang Y, Wang Y. gC1qR: A New Target for Cancer Immunotherapy. Front Immunol 2023;14. [DOI: 10.3389/fimmu.2023.1095943] [Reference Citation Analysis]
|
3 |
Malacrida A, Deschamps-Wright M, Rigolio R, Cavaletti G, Miloso M. Another Brick to Confirm the Efficacy of Rigosertib as Anticancer Agent. Int J Mol Sci 2023;24. [PMID: 36675237 DOI: 10.3390/ijms24021721] [Reference Citation Analysis]
|
4 |
Han C, Zhan Q. Precision medicine revolutionizes cancer diagnosis and treatment. Medical Review 2023;0. [DOI: 10.1515/mr-2022-0041] [Reference Citation Analysis]
|
5 |
Sun Y, Yang M, Zhang Q. Analysis of C-X-C motif chemokine receptors in breast cancer: potential value in immunotherapy and prognostic prediction. Ann Transl Med 2022;10:1379. [PMID: 36660642 DOI: 10.21037/atm-22-6056] [Reference Citation Analysis]
|
6 |
Gu GJ, Chung H, Park JY, Yoo RJ, Im HJ, Choi H, Lee Y, Seok SH. Mannosylated-Serum Albumin Nanoparticle Imaging to Monitor Tumor-Associated Macrophages under Anti- PD1 Treatment.. [DOI: 10.21203/rs.3.rs-2209638/v1] [Reference Citation Analysis]
|